Cannara Biotech, LOVFF stock, has been on my radar for a moment. They have been hitting my Top 10 videos here and there, and I have taken notice. The two questions I have are: Is the revenue growth sustainable and potentially continuous? And, would this translate into a solidly performing cannabis stock? I wonder if Cannara Biotech is an undervalued marijuana stock to buy now?Cannara Biotech is an undervalued marijuana stock to buy now? There was a substantial gain in revenues that really pushed Cannara Biotech LOVFF stock into the limelight. This was driven by the full-quarter revenue gains for their newly opened dispensary. Also, Cannara Biotech is expanding into a new 1M sq. ft. facility that will help them expand offerings and, this will be beneficial long term. As Cannara Biotech grows its offerings, this will allow for them to control costs. Eventually, the current costs will be outsized by future revenues. This makes for a long term investment with a big-picture outlook. Another plus over the past quarter was a refinancing of credit facility that dropped interest costs from 13% down to a much more manageable 4%. If a lender is going to drop interest rates for lending a company money this shows that there are a lot of positive aspects of the company’s future potential.